Skip to main content

Silvia Sánchez Martín

Institutions of which they are part

Postdoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Silvia Sánchez Martín

Institutions of which they are part

Postdoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

Related professionals

Iván Martínez Ballestero

Iván Martínez Ballestero

Predoctoral researcher
Pneumology
Read more
Mª Carmen López  Arribas

Mª Carmen López Arribas

Research technician
Molecular Imaging and Therapy
Read more
Celia Sánchez Campaña

Celia Sánchez Campaña

Predoctoral researcher
Infectious Diseases
Read more
Manuel Armengol Carrasco

Manuel Armengol Carrasco

Head of group
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.